Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- ACE inhibitor (1)
- Amantadine (1)
- Angioedema (1)
- Angiotensin-converting enzyme inhibitor (1)
- Anoxic brain injury (1)
-
- Arousal (1)
- Cannabidiol (1)
- Cognition (1)
- Dravet syndrome (1)
- Epilepsy (1)
- Factor Xa inhibitor reversal (1)
- Fondaparinux (1)
- Heparin-induced thrombocytopenia (1)
- Icatibant (1)
- Intracranial hemorrhage (1)
- Rehabilitation (1)
- Seizures (1)
- Severe traumatic brain injury (1)
- Thrombin inhibitors (1)
- Tofacitinib (1)
- Ulcerative colitis (1)
Articles 1 - 6 of 6
Full-Text Articles in Medicine and Health Sciences
Fondaparinux Is An Effective Alternative To Other Non-Heparin Anticoagulants In The Treatment Of Heparin-Induced Thrombocytopenia, Allan J. Brazier Jr.
Fondaparinux Is An Effective Alternative To Other Non-Heparin Anticoagulants In The Treatment Of Heparin-Induced Thrombocytopenia, Allan J. Brazier Jr.
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Kang M, Alahmadi M, Sawh S, Kovacs MJ, Lazo-Langner A. Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study. Blood. 2014;125(6):924-929. doi: 10.1182/blood-2014-09-599498.
Amantadine Minimally Improves Arousal In Patients With Severe Traumatic Brain Injury, Michelle Eventov
Amantadine Minimally Improves Arousal In Patients With Severe Traumatic Brain Injury, Michelle Eventov
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Giacino JT, Whyte J, Bagiella E, et al. Placebo-Controlled Trial of Amantadine for Severe Traumatic Brain Injury. New England Journal of Medicine. 2012;366(9):819-826. doi: 10.1056/nejmoa1102609.
Weighing Harms, Benefits, And Alternatives For A Young Man With A Recent Flare Of Ulcerative Colitis, Louise B. Welsh
Weighing Harms, Benefits, And Alternatives For A Young Man With A Recent Flare Of Ulcerative Colitis, Louise B. Welsh
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Sandborn WJ, Su C, Sands B, et al. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis. N Engl J Med. 2017 May 4;376(18):1723-1736. doi: 10.1056/NEJMoa1606910
Andexanet Alfa Is An Effective Reversal Agent For Factor Xa Inhibitors In Patients That Develop Intracranial Hemorrhage, Joseph Friedli
Andexanet Alfa Is An Effective Reversal Agent For Factor Xa Inhibitors In Patients That Develop Intracranial Hemorrhage, Joseph Friedli
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Connolly SJ, Milling TJ, Eikelboom JW, et al. Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. N Engl J Med. 2016;375(12):1131-1141. doi: 10.1056/NEJMoa1607887.
Cannabidiol Is Beneficial In Management Of Drug-Resistant Dravet Syndrome, Nikita Desai
Cannabidiol Is Beneficial In Management Of Drug-Resistant Dravet Syndrome, Nikita Desai
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Devinsky O, Cross H, Laux L, et al. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. N Engl J Med. 2017;376(21):2011-2020. doi: 10.1056/NEJMoa1611618.
Icatibant Is Not Helpful For The Treatment Of Ace Inhibitor-Induced Angioedema, Samantha R. Schwartz
Icatibant Is Not Helpful For The Treatment Of Ace Inhibitor-Induced Angioedema, Samantha R. Schwartz
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Sinert R, Levy P, Bernstein JA, et al. Randomized trial of icatibant for angiotensin-converting enzyme inhibitor-induced upper airway angioedema. J Allergy Clin Immunol Pract. 2017; 5(5): 1402-1409. doi: 10.1016/j.jaip.2017.03.003.